IL96083A - Pharmaceutical compositions comprising (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure - Google Patents

Pharmaceutical compositions comprising (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure

Info

Publication number
IL96083A
IL96083A IL96083A IL9608390A IL96083A IL 96083 A IL96083 A IL 96083A IL 96083 A IL96083 A IL 96083A IL 9608390 A IL9608390 A IL 9608390A IL 96083 A IL96083 A IL 96083A
Authority
IL
Israel
Prior art keywords
imidazolin
ylamino
carbon atoms
quinoxalines
reduce
Prior art date
Application number
IL96083A
Other languages
English (en)
Other versions
IL96083A0 (en
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of IL96083A0 publication Critical patent/IL96083A0/xx
Publication of IL96083A publication Critical patent/IL96083A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL96083A 1989-10-31 1990-10-22 Pharmaceutical compositions comprising (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure IL96083A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/429,835 US5021416A (en) 1989-10-31 1989-10-31 Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure

Publications (2)

Publication Number Publication Date
IL96083A0 IL96083A0 (en) 1991-07-18
IL96083A true IL96083A (en) 1997-06-10

Family

ID=23704912

Family Applications (1)

Application Number Title Priority Date Filing Date
IL96083A IL96083A (en) 1989-10-31 1990-10-22 Pharmaceutical compositions comprising (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure

Country Status (18)

Country Link
US (1) US5021416A (de)
EP (1) EP0426390B1 (de)
JP (1) JP2999240B2 (de)
KR (1) KR910007530A (de)
AT (1) ATE122233T1 (de)
AU (1) AU627626B2 (de)
CA (1) CA2025189A1 (de)
DE (1) DE69019297T2 (de)
ES (1) ES2074138T3 (de)
FI (1) FI905369A7 (de)
HU (1) HU207946B (de)
IE (1) IE68413B1 (de)
IL (1) IL96083A (de)
NZ (1) NZ235884A (de)
PH (1) PH26978A (de)
RU (1) RU1829937C (de)
TW (1) TW218352B (de)
ZA (1) ZA908731B (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112822A (en) * 1989-10-12 1992-05-12 Allergan, Inc. (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
US5326763A (en) * 1989-10-12 1994-07-05 Allergan, Inc. Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
US5231096A (en) * 1989-10-12 1993-07-27 Allergan, Inc. Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
US5077292A (en) * 1989-10-12 1991-12-31 Allergan, Inc. (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same
AU688380B2 (en) * 1993-10-13 1998-03-12 Allergan, Inc. Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
US6323204B1 (en) 1993-10-13 2001-11-27 Allergan Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
CN1046718C (zh) * 1993-12-17 1999-11-24 普罗克特和甘保尔公司 用作α-2肾上腺素能受体兴奋剂的6-(2-亚咪唑烷基氨基)喹啉化合物
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
DE69425334T2 (de) * 1993-12-17 2001-02-08 The Procter & Gamble Company, Cincinnati 6-(2-imidazolinylamino) chinoxalin-verbindungen als alpha-2-adrenorezeptoragonisten
US5576437A (en) * 1993-12-17 1996-11-19 The Procter & Gamble Company 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
US5578607A (en) * 1993-12-17 1996-11-26 The Procter & Gamble Company 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
US5856329A (en) * 1995-06-28 1999-01-05 Allergan Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
US6194415B1 (en) 1995-06-28 2001-02-27 Allergan Sales, Inc. Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury
US5916900A (en) * 1995-06-29 1999-06-29 The Procter & Gamble Company 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
ATE271048T1 (de) 1997-11-24 2004-07-15 Procter & Gamble 5-(2-imidazolinylamino)-benzimidazol derivate, deren herstellung und deren verwendung als .alpha.-adrenoceptor agonisten mit verbesserter metabolischer stabilität
US6329369B1 (en) 1997-12-04 2001-12-11 Allergan Sales, Inc. Methods of treating pain and other conditions
US6841684B2 (en) 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
EP1365811A2 (de) 2000-07-14 2003-12-03 Allergan, Inc. Zusammensetzungen enthaltend alpha-2-adrenergische agonisten
CA2416169C (en) * 2000-07-14 2008-09-23 Allergan, Inc. Compositions containing therapeutically active components having enhanced solubility
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20040214829A1 (en) * 2000-07-14 2004-10-28 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20050026924A1 (en) * 2000-07-14 2005-02-03 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
WO2002089853A2 (en) * 2001-05-03 2002-11-14 Allergan, Inc. Compositions having enhanced pharmacokinetic characteristics
US20020198210A1 (en) * 2001-05-03 2002-12-26 Allergan Sales Inc. Alpha-2-adrenergic agonist/fatty acid compositions
US20020198209A1 (en) 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
US7030149B2 (en) 2002-04-19 2006-04-18 Allergan, Inc. Combination of brimonidine timolol for topical ophthalmic use
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
EP1654002B2 (de) * 2003-08-07 2014-01-29 Allergan, Inc. Zusammensetzungen zur abgabe von therapeutika in die augen
WO2008144399A1 (en) * 2007-05-18 2008-11-27 Bausch & Lomb Incorporated COMPLEXES COMPRISING α2-ADRENERGIC RECEPTOR AGONISTS AND COMPOSITIONS
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
US7842714B2 (en) 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US20100202979A1 (en) * 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of pulmonary diseases and conditions
US20100203165A1 (en) 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of disorders or conditions of the eye
US8952011B2 (en) 2008-08-01 2015-02-10 Eye Therapies Llc Compositions and methods for the treatment of nasal conditions
US12246013B2 (en) 2008-08-01 2025-03-11 Eye Therapies Llc Vasoconstriction compositions and methods of use
US20110003823A1 (en) * 2008-08-01 2011-01-06 Alpha Synergy Development, Inc. Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage
US20100028266A1 (en) * 2008-08-01 2010-02-04 Alpha Synergy Development. Inc. Composition and methods for treating allergic response
US20180369240A1 (en) * 2008-08-01 2018-12-27 Eye Therapies Llc Preferential Vasoconstriction Compositions and Methods of Use
US20100197694A1 (en) * 2008-08-01 2010-08-05 Gerald Horn Compositions and methods for treatment of diseases and conditions with increased vascular permeability
US8987270B2 (en) 2009-07-27 2015-03-24 Eye Therapies Llc Formulations of selective alpha-2 agonists and methods of use thereof
EP2329849B1 (de) 2009-11-18 2015-04-29 Galderma Research & Development Kombination aus einem Alpha-2-Adrenozeptor-Agonisten und einem nichtsteroidalen entzündungshemmenden Mittel zur Behandlung oder Prävention einer Entzündungskrankheit der Haut
US8394800B2 (en) * 2009-11-19 2013-03-12 Galderma Laboratories, L.P. Method for treating psoriasis
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
CN103298472A (zh) 2010-03-26 2013-09-11 盖尔德马研究及发展公司 安全和有效治疗红斑的改进的方法和组合物
WO2011117378A2 (en) 2010-03-26 2011-09-29 Galderma Research & Development Improved methods and compositions for safe and effective treatment of telangiectasia
EP2555750A2 (de) 2010-04-07 2013-02-13 Allergan, Inc. Kombinationen aus konservierungsstoffzusammensetzungen für ophthalmische formulierungen
KR20130041803A (ko) 2010-04-07 2013-04-25 알러간, 인코포레이티드 안과 조성물을 위한 보존제의 조합
PT2598119T (pt) 2010-07-29 2018-12-17 Allergan Inc Soluções de brimonidina e timolol isentas de conservantes
ES2498217T5 (es) 2010-10-21 2018-03-19 Galderma S.A. Composición en forma de gel basada en brimonidina
US8053427B1 (en) 2010-10-21 2011-11-08 Galderma R&D SNC Brimonidine gel composition
JP6339364B2 (ja) * 2013-12-27 2018-06-06 カズマパートナーズ株式会社 無定形ブリモニジン酒石酸塩及びその製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
GB1463520A (en) * 1974-09-06 1977-02-02 Pfizer Ltd Process for the production of imidazolines
US5077292A (en) * 1989-10-12 1991-12-31 Allergan, Inc. (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same

Also Published As

Publication number Publication date
EP0426390A2 (de) 1991-05-08
JP2999240B2 (ja) 2000-01-17
HU906934D0 (en) 1991-05-28
ZA908731B (en) 1991-07-31
AU627626B2 (en) 1992-08-27
FI905369A0 (fi) 1990-10-30
AU6396690A (en) 1991-05-09
EP0426390A3 (en) 1992-03-04
DE69019297T2 (de) 1995-10-12
KR910007530A (ko) 1991-05-30
CA2025189A1 (en) 1991-05-01
NZ235884A (en) 1997-08-22
HUT57045A (en) 1991-11-28
FI905369A7 (fi) 1991-05-01
IL96083A0 (en) 1991-07-18
RU1829937C (ru) 1993-07-23
IE68413B1 (en) 1996-06-12
US5021416A (en) 1991-06-04
ES2074138T3 (es) 1995-09-01
TW218352B (de) 1994-01-01
JPH03153626A (ja) 1991-07-01
HU207946B (en) 1993-07-28
EP0426390B1 (de) 1995-05-10
ATE122233T1 (de) 1995-05-15
IE903896A1 (en) 1991-05-08
DE69019297D1 (de) 1995-06-14
PH26978A (en) 1992-12-28

Similar Documents

Publication Publication Date Title
AU627626B2 (en) Method for using (2-imidazolin-2-ylamino)quinoxalines to reduce or maintain intraocular pressure
AU628666B2 (en) (2-imidazolin-2-ylamino) tetrahydro-quinoxalines and methods for using same
CA2064815A1 (en) Therapeutic heterocyclic compounds
ES8306141A1 (es) Un procedimiento para la produccion de un derivado de carbostirilo
ES486349A1 (es) Procedimiento para la preparacion de 5-(2-imidazolin-2-il)- aminopirimidinas
CA1251209A (en) DISHYDROPYRIDAZINONE DERIVATIVES
IL108259A0 (en) Piperazine derivates, their preparation and pharmaceutical compositions containing them
HUT65574A (en) Process for preparing 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and pharmaceutical compositions containing them
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
ES8500888A1 (es) Un procedimiento para la preparacion de nuevos derivados de propanolamina.
ES8501410A1 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
GB2115815B (en) Benzothiazoline compounds
IL100484A (en) Pharmaceutical compositions containing 1H-benz [b] azepine 2,5 dione derivatives some such novel compounds and process for their preparation
IE893956L (en) Novel compounds
ATE42292T1 (de) Imidazo(1,2-c)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
ES8501382A1 (es) Procedimiento para la preparacion de derivados de acido fenilacetico.
ES8405020A1 (es) Un procedimiento para la preparacion de derivados de fosfolipidos.
GB8610369D0 (en) Heterocyclic compounds
ES8301482A1 (es) Un procedimiento para la preparacion de un derivado del aci-do clavulanico

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees